To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TAF3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
118 supporting clones for gene TAF3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AJ292190   .a 234 to 2414 1 to 2181 tiling clone,   2181/2182
(99 %)
1 diff
(100.0 %id)
AK123254 amygdala .a 4525 to 6901 1 to 2377 tiling clone, available from FLJ,   2377/2377
(100 %)
3 diff
(99.9 %id)
AK307521 brain .a 52 to 2433 1 to 2379     2382/2379
(100 %)
5 diff
(99.8 %id)
AK307657 testis .a 50 to 1832 1 to 1783     1783/1783
(100 %)
5 diff
(99.8 %id)
AL117661 uterus .a 307 to 2325 8 to 2026 available from DKFZ, AAA   2019/2019
(100 %)
1 diff
(100.0 %id)
AW859598 colon .a 930 to 1426 1 to 497     497/497
(100 %)
3 diff
(99.4 %id)
AW974322   .a 1274 to 1823 554 to 3   Submitted on the opposite strand 552/554
(99 %)
0 diff
(100 %id)
AW977721   .a 4247 to 4898 653 to 1   Submitted on the opposite strand 653/654
(99 %)
20 diff
(97.0 %id)
BF741143 bocio_tumor .a 1776 to 2198 1 to 424     424/424
(100 %)
7 diff
(98.4 %id)
BG996577 head_neck .a 3403 to 3783 23 to 402     380/410
(92 %)
2 diff
(99.6 %id)
BI037105 nervous_tumor .a 1770 to 2066 307 to 6     302/307
(98 %)
0 diff
(100 %id)
BQ321967 colon .a 1662 to 1958 303 to 7     297/303
(98 %)
0 diff
(100 %id)
BQ325946 colon_ins .a 1383 to 1911 535 to 7     529/535
(98 %)
0 diff
(100 %id)
DA172142 amygdala .a 4526 to 4829 2 to 305 capped   304/304
(100 %)
0 diff
(100 %id)
DB302620 amygdala .a 6352 to 6901 554 to 1     554/554
(100 %)
5 diff
(99.1 %id)
DA260330 caudate nucleus .a 50 to 626 2 to 579 capped   578/578
(100 %)
1 diff
(99.9 %id)
DA367770 subthalamic nucleus .a 42 to 585 2 to 545 capped   544/544
(100 %)
0 diff
(100 %id)
BX094325   .a 3690 to 4128 1 to 439 AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 439/439
(100 %)
0 diff
(100 %id)
BX113502 lung .a 1508 to 1981 1 to 474     474/474
(100 %)
1 diff
(99.8 %id)
DA419450 cord Blood .a 30 to 583 2 to 555 capped   554/554
(100 %)
0 diff
(100 %id)
CN394033 embryonic stem cells, DMSO-treated H9 cellline .a 1080 to 1478 1 to 400     400/400
(100 %)
3 diff
(99.3 %id)
CN394034 embryonic stem cells, cell lines H1, H7, andH9 .a 1002 to 1715 1 to 716     716/716
(100 %)
4 diff
(99.5 %id)
CN394035 embryonic stem cells, cell lines H1, H7, andH9 .a 76 to 401 1 to 326     326/326
(100 %)
0 diff
(100 %id)
CN394036 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 413 to 897 1 to 485     485/485
(100 %)
0 diff
(100 %id)
CR746734 epithelioid carcinoma, Pancreas .a 2523 to 3024 4 to 505 tiling clone,   502/505
(99 %)
6 diff
(98.9 %id)
CA397451 eye, RPE/choroid .a 407 to 955 1 to 549     549/549
(100 %)
0 diff
(100 %id)
DA465610   .a 30 to 601 2 to 573 capped   572/572
(100 %)
0 diff
(100 %id)
AL042512 testis .a 2944 to 3325 437 to 44   Submitted on the opposite strand 394/440
(89 %)
0 diff
(100 %id)
DN919024   .a 1821 to 2120 311 to 10     302/323
(93 %)
0 diff
(100 %id)
DT217358 brain .a 809 to 1481 1 to 672     672/672
(100 %)
6 diff
(99.2 %id)
DW461169 Liver .a 4652 to 4765 17 to 130     114/130
(87 %)
0 diff
(100 %id)
EH336262   .a 831 to 902 1 to 72     72/72
(100 %)
0 diff
(100 %id)
DA511276 brain .a 53 to 609 2 to 559 capped   558/558
(100 %)
1 diff
(99.9 %id)
CD672928 eye, Iris .a 1623 to 1754 1 to 132     132/132
(100 %)
0 diff
(100 %id)
FN064746 breast carcinoma .a 722 to 804 1 to 83     83/83
(100 %)
2 diff
(97.6 %id)
FN105065 breast carcinoma .a 1509 to 1619 1 to 107     107/107
(100 %)
4 diff
(96.3 %id)
FN162081 breast carcinoma .a 4790 to 4901 1 to 114     114/117
(97 %)
4 diff
(96.6 %id)
DB496395 hypothalamus .a 49 to 519 1 to 471     471/471
(100 %)
2 diff
(99.6 %id)
DB567418 hypothalamus .a 1385 to 1832 1 to 448   Submitted on the opposite strand 448/448
(100 %)
1 diff
(99.8 %id)
BQ639837 eye, retina .a 41 to 586 1 to 541     541/541
(100 %)
8 diff
(98.6 %id)
BP872677 embryonal kidney .a 29 to 615 1 to 587     587/587
(100 %)
4 diff
(99.4 %id)
R00290 liver and spleen .a 1467 to 1827 372 to 7     366/375
(97 %)
0 diff
(100 %id)
T99942 liver and spleen .a 793 to 1076 1 to 286     286/389
(73 %)
7 diff
(98.3 %id)
AA777658 liver and spleen .a 1331 to 1826 496 to 1     496/496
(100 %)
4 diff
(99.2 %id)
AA826691 invasive tumor (cell line), Prostate .a 1399 to 1828 430 to 1     430/430
(100 %)
3 diff
(99.4 %id)
AA827118 germinal center B cell .a 4508 to 4899 412 to 21 AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 392/392
(100 %)
0 diff
(100 %id)
AA910049 pooled .a 3781 to 4153 383 to 11 AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 373/373
(100 %)
0 diff
(100 %id)
AA927947 pooled .a 3702 to 4130 429 to 1     429/429
(100 %)
0 diff
(100 %id)
AA918543 pooled .a 3012 to 3325 327 to 16 AAA   312/312
(100 %)
2 diff
(99.4 %id)
AA933921 pooled .a 3207 to 3325 134 to 16 AAA   119/119
(100 %)
0 diff
(100 %id)
AI002323 carcinoid, lung .a 3779 to 4127 349 to 1     349/349
(100 %)
0 diff
(100 %id)
AI081790 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3650 to 4124 474 to 1     474/474
(100 %)
2 diff
(99.6 %id)
AI123516 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3611 to 4134 524 to 1 tiling clone,   524/524
(100 %)
0 diff
(100 %id)
AI218666   .a 3738 to 4128 415 to 25 AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 391/391
(100 %)
0 diff
(100 %id)
AI363141 anaplastic oligodendroglioma, brain .a 1403 to 1830 431 to 4     428/431
(99 %)
0 diff
(100 %id)
AI364321 anaplastic oligodendroglioma, brain .a 1380 to 1832 453 to 1     453/453
(100 %)
0 diff
(100 %id)
AI570472 anaplastic oligodendroglioma, brain .a 688 to 1151 464 to 1     464/464
(100 %)
0 diff
(100 %id)
AI554630 anaplastic oligodendroglioma, brain .a 1331 to 1830 504 to 5     500/504
(99 %)
0 diff
(100 %id)
AI554695 anaplastic oligodendroglioma, brain .a 1343 to 1830 492 to 5     488/492
(99 %)
0 diff
(100 %id)
AI700755 carcinoid, lung .a 3654 to 4131 478 to 1     478/478
(100 %)
3 diff
(99.4 %id)
AI921106 adenocarcinoma, Pancreas .a 1881 to 2354 474 to 1     474/474
(100 %)
2 diff
(99.6 %id)
AI978684 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1559 to 2081 524 to 1     524/527
(99 %)
2 diff
(99.7 %id)
AI961947 adenocarcinoma, Pancreas .a 3446 to 3815 371 to 2     370/371
(99 %)
0 diff
(100 %id)
AW005174 anaplastic oligodendroglioma, brain .a 616 to 1151 536 to 1     536/536
(100 %)
0 diff
(100 %id)
AW591090 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1997 to 2360 364 to 1     364/364
(100 %)
2 diff
(99.5 %id)
AW614150 Kidney .a 2965 to 3325 362 to 2     361/362
(99 %)
0 diff
(100 %id)
BF513064   .a 4254 to 4899 663 to 18 tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
BF510647   .a 3081 to 3325 262 to 18 AAA   245/245
(100 %)
2 diff
(99.2 %id)
BQ027547 mixed .a 3633 to 4123 509 to 19 AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 491/491
(100 %)
0 diff
(100 %id)
BF063144 colon, colon tumor, RER+ .a 2817 to 3319 508 to 5     504/508
(99 %)
3 diff
(99.5 %id)
BC017320 Skin, melanotic melanoma. .a 42 to 1832 1 to 1791 available from MGC, AAA   1791/1791
(100 %)
1 diff
(100.0 %id)
BE277645 melanotic melanoma, skin .a 42 to 533 26 to 516 available from MGC,   491/518
(94 %)
8 diff
(98.5 %id)
BC045106 Uterus, endometrium adenocarcinoma .a 42 to 1832 1 to 1791 available from MGC, AAA   1791/1791
(100 %)
1 diff
(100.0 %id)
BE391746 endometrium, adenocarcinoma cell line, uterus .a 42 to 642 26 to 626 available from MGC,   601/710
(84 %)
9 diff
(98.8 %id)
BE391563 endometrium, adenocarcinoma cell line, uterus .a 42 to 642 43 to 642     600/768
(78 %)
9 diff
(98.9 %id)
BC062352 Skin, melanotic melanoma. .a 62 to 2327 1 to 2267 available from MGC, AAA   2267/2267
(100 %)
4 diff
(99.9 %id)
BE384665 melanotic melanoma, skin .a 81 to 642 1 to 564 available from MGC,   564/765
(73 %)
4 diff
(99.5 %id)
BF433436 carcinoid, lung .a 3513 to 3815 306 to 4     303/306
(99 %)
0 diff
(100 %id)
BE895182 melanotic melanoma, skin .a 3311 to 3825 1 to 514 AAA   514/514
(100 %)
1 diff
(99.9 %id)
BG107418 Bone, osteosarcoma, cell line .a 3006 to 3822 1 to 814     814/886
(91 %)
31 diff
(96.6 %id)
BC073884 Bone, osteosarcoma .a 37 to 1826 1 to 1790 available from MGC, AAA   1790/1790
(100 %)
0 diff
(100 %id)
BG109617 Bone, osteosarcoma, cell line .a 37 to 642 1 to 607 available from MGC,   607/669
(90 %)
2 diff
(99.8 %id)
BG106433 lymph, lymphoma, cell line .a 2866 to 3657 1 to 786     786/796
(98 %)
29 diff
(96.4 %id)
BF980500 duodenal adenocarcinoma, cell line, small intestine .a 3057 to 3796 1 to 733     733/912
(80 %)
11 diff
(98.8 %id)
BG250498 adenocarcinoma, cell line, Liver .a 1880 to 2333 1 to 457     457/585
(78 %)
5 diff
(99.2 %id)
BC024661 Bladder, transitional cell papilloma .a 1533 to 2406 1 to 874 AAA   874/1143
(76 %)
9 diff
(99.3 %id)
BG260895 bladder, transitional cell papilloma, cell line .a 1533 to 2334 1 to 801     801/975
(82 %)
31 diff
(96.9 %id)
BC105593 Testis, embryonal carcinoma .a 24 to 1059 1 to 1036 AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1036/1060
(97 %)
4 diff
(99.7 %id)
BG503224 embryonal carcinoma, testis .a 27 to 642 1 to 617     617/713
(86 %)
4 diff
(99.5 %id)
BC028077 Blood, adult leukocytes .a 71 to 2327 1 to 2257 available from MGC, AAA   2257/2257
(100 %)
3 diff
(99.9 %id)
BI908126 leukocyte .a 71 to 924 1 to 859 available from MGC,   859/859
(100 %)
16 diff
(98.2 %id)
BM904502 leiomyosarcoma, uterus .a 3114 to 3984 1 to 878     878/1112
(78 %)
34 diff
(97.0 %id)
BQ049213 lymph, lymphoma, cell line .a 904 to 1887 40 to 1038     999/1047
(95 %)
33 diff
(96.9 %id)
BQ230871 epithelioid carcinoma, Pancreas .a 2532 to 3211 1 to 689     689/967
(71 %)
19 diff
(98.1 %id)
BQ923868 leiomyosarcoma, uterus .a 3607 to 4509 1 to 910 tiling clone,   910/912
(99 %)
30 diff
(96.8 %id)
CX165629 human embryonic stem cells differentiated toan early endodermal cell type .a 2924 to 3748 1 to 825 tiling clone,   825/825
(100 %)
0 diff
(100 %id)
CX871057 embryonic stem .a 1682 to 2436 1 to 755 tiling clone,   755/755
(100 %)
2 diff
(99.8 %id)
CX755577 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1027 to 1738 1 to 708   Submitted on the opposite strand 708/758
(93 %)
6 diff
(99.3 %id)
TI_57235495   .a 63 to 924 26 to 892     867/892
(97 %)
23 diff
(97.5 %id)
CB118706 Liver .a 489 to 1092 1 to 602     602/602
(100 %)
2 diff
(99.7 %id)
NM_031923.2   .a 234 to 3023 1 to 2790 RefSeq,   2790/2790
(100 %)
0 diff
(100 %id)
DA700284   .a 49 to 530 2 to 484 capped   483/483
(100 %)
3 diff
(99.4 %id)
DA743721   .a 1 to 525 2 to 526 tiling clone, capped   525/525
(100 %)
0 diff
(100 %id)
DA769109 brain .a 50 to 556 2 to 508 capped   507/507
(100 %)
0 diff
(100 %id)
DA835937 placenta .a 54 to 496 15 to 458 capped   444/444
(100 %)
1 diff
(99.8 %id)
CR992112 T-Lymphocytes .a 105 to 1049 1 to 941     941/941
(100 %)
6 diff
(99.4 %id)
DN992507 brain, whole brain .a 92 to 749 1 to 657     657/657
(100 %)
5 diff
(99.3 %id)
BM152698 leukopheresis .a 42 to 300 1 to 259     259/259
(100 %)
6 diff
(97.7 %id)
DB028381 testis .a 51 to 593 2 to 545 capped   544/544
(100 %)
2 diff
(99.7 %id)
DB046873 testis .a 50 to 605 2 to 557 capped   556/556
(100 %)
0 diff
(100 %id)
DB059283 testis .a 50 to 593 2 to 545 capped   544/544
(100 %)
2 diff
(99.7 %id)
DB145297 thymus .a 50 to 584 2 to 536 capped   535/535
(100 %)
0 diff
(100 %id)
DB205084 trachea .a 50 to 641 2 to 593 capped   592/598
(98 %)
1 diff
(99.9 %id)
BM671518 eye, Retina Foveal and Macular .a 3601 to 3814 232 to 19 AAA   214/214
(100 %)
6 diff
(97.2 %id)
BM704312 eye, Retina Foveal and Macular .a 3004 to 3534 1 to 531     531/531
(100 %)
0 diff
(100 %id)
BU625123 cell lines, Enchondroma .a 2724 to 3325 620 to 19 AAA   602/602
(100 %)
3 diff
(99.6 %id)
BU618891 Cell Line, Chondrosarcoma .a 1832 to 2375 544 to 2 AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 543/544
(99 %)
0 diff
(100 %id)
BP873338 embryonal kidney .a 1533 to 2334 1 to 801   This clone was ignored 801/975
(82 %)
31 diff
(96.9 %id)
N70895 lung .a 1533 to 2334 1 to 801     801/975
(82 %)
31 diff
(96.9 %id)
W06920 lung .a 24 to 1059 1 to 1036     1036/1060
(97 %)
4 diff
(99.7 %id)
TI_149290943   .a 27 to 642 1 to 617 AAA This clone was ignored 617/713
(86 %)
4 diff
(99.5 %id)
BU681978 lung .a 27 to 642 1 to 617 AAA This clone was ignored 617/713
(86 %)
4 diff
(99.5 %id)
BC028077 Blood, adult leukocytes .a 71 to 2327 1 to 2257 available from MGC, AAA   2257/2257
(100 %)
3 diff
(99.9 %id)
BI908126 leukocyte .a 71 to 924 1 to 859 available from MGC,   859/859
(100 %)
16 diff
(98.2 %id)
BM904502 leiomyosarcoma, uterus .a 3114 to 3984 1 to 878     878/1112
(78 %)
34 diff
(97.0 %id)
BM904502 leiomyosarcoma, uterus .a 3114 to 3984 1 to 878     878/1112
(78 %)
34 diff
(97.0 %id)
BQ049213 lymph, lymphoma, cell line .a 904 to 1887 40 to 1038     999/1047
(95 %)
33 diff
(96.9 %id)
BQ049213 lymph, lymphoma, cell line .a 904 to 1887 40 to 1038     999/1047
(95 %)
33 diff
(96.9 %id)
BQ230871 epithelioid carcinoma, Pancreas .a 2532 to 3211 1 to 689     689/967
(71 %)
19 diff
(98.1 %id)
BQ230871 epithelioid carcinoma, Pancreas .a 2532 to 3211 1 to 689     689/967
(71 %)
19 diff
(98.1 %id)
BQ923868 leiomyosarcoma, uterus .a 3607 to 4509 1 to 910 tiling clone,   910/912
(99 %)
30 diff
(96.8 %id)
BQ923868 leiomyosarcoma, uterus .a 3607 to 4509 1 to 910 tiling clone,   910/912
(99 %)
30 diff
(96.8 %id)
CX165629 human embryonic stem cells differentiated toan early endodermal cell type .a 2924 to 3748 1 to 825 tiling clone,   825/825
(100 %)
0 diff
(100 %id)
CX871057 embryonic stem .a 1682 to 2436 1 to 755 tiling clone,   755/755
(100 %)
2 diff
(99.8 %id)
CX755577 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1027 to 1738 1 to 708   Submitted on the opposite strand 708/758
(93 %)
6 diff
(99.3 %id)
CX755577 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1027 to 1738 1 to 708   Submitted on the opposite strand 708/758
(93 %)
6 diff
(99.3 %id)
TI_57235495   .a 63 to 924 26 to 892     867/892
(97 %)
23 diff
(97.5 %id)
CB118706 Liver .a 489 to 1092 1 to 602     602/602
(100 %)
2 diff
(99.7 %id)
NM_031923.2   .a 234 to 3023 1 to 2790 RefSeq,   2790/2790
(100 %)
0 diff
(100 %id)
DA700284   .a 49 to 530 2 to 484 capped   483/483
(100 %)
3 diff
(99.4 %id)
DA743721   .a 1 to 525 2 to 526 tiling clone, capped   525/525
(100 %)
0 diff
(100 %id)
DA769109 brain .a 50 to 556 2 to 508 capped   507/507
(100 %)
0 diff
(100 %id)
DA835937 placenta .a 54 to 496 15 to 458 capped   444/444
(100 %)
1 diff
(99.8 %id)
CR992112 T-Lymphocytes .a 105 to 1049 1 to 941     941/941
(100 %)
6 diff
(99.4 %id)
DN992507 brain, whole brain .a 92 to 749 1 to 657     657/657
(100 %)
5 diff
(99.3 %id)
DN992507 brain, whole brain .a 92 to 749 1 to 657     657/657
(100 %)
5 diff
(99.3 %id)
BM152698 leukopheresis .a 42 to 300 1 to 259     259/259
(100 %)
6 diff
(97.7 %id)
DB028381 testis .a 51 to 593 2 to 545 capped   544/544
(100 %)
2 diff
(99.7 %id)
DB046873 testis .a 50 to 605 2 to 557 capped   556/556
(100 %)
0 diff
(100 %id)
DB059283 testis .a 50 to 593 2 to 545 capped   544/544
(100 %)
2 diff
(99.7 %id)
DB145297 thymus .a 50 to 584 2 to 536 capped   535/535
(100 %)
0 diff
(100 %id)
DB205084 trachea .a 50 to 641 2 to 593 capped   592/598
(98 %)
1 diff
(99.9 %id)
BM671518 eye, Retina Foveal and Macular .a 3601 to 3814 232 to 19 AAA   214/214
(100 %)
6 diff
(97.2 %id)
BM671518 eye, Retina Foveal and Macular .a 3601 to 3814 232 to 19 AAA   214/214
(100 %)
6 diff
(97.2 %id)
BM704312 eye, Retina Foveal and Macular .a 3004 to 3534 1 to 531     531/531
(100 %)
0 diff
(100 %id)
BM704312 eye, Retina Foveal and Macular .a 3004 to 3534 1 to 531     531/531
(100 %)
0 diff
(100 %id)
BU625123 cell lines, Enchondroma .a 2724 to 3325 620 to 19 AAA   602/602
(100 %)
3 diff
(99.6 %id)
BU625123 cell lines, Enchondroma .a 2724 to 3325 620 to 19 AAA   602/602
(100 %)
3 diff
(99.6 %id)
BU618891 Cell Line, Chondrosarcoma .a 1832 to 2375 544 to 2 AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 543/544
(99 %)
0 diff
(100 %id)
BU618891 Cell Line, Chondrosarcoma .a 1832 to 2375 544 to 2 AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 543/544
(99 %)
0 diff
(100 %id)
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes CI